Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy

被引:28
|
作者
Tu, Yugang [1 ]
Wu, Tieqiao [1 ]
Dai, Aozhi [1 ]
Pham, Yen [1 ]
Chew, Phyllis [1 ]
de Haan, Judy B. [1 ]
Wang, Yu [1 ]
Toh, Ban-Hock [2 ]
Zhu, Hongjian [3 ]
Cao, Zemin [1 ]
Cooper, Mark E. [1 ,4 ]
Chai, Zhonglin [1 ]
机构
[1] Baker IDI Heart & Diabet Inst, Diabet & Metab Div, Melbourne, Vic 3004, Australia
[2] Monash Univ, Autoimmun Lab, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia
[3] Univ Melbourne, Dept Surg RMH, Parkville, Vic 3052, Australia
[4] Monash Univ, Fac Med, Dept Immunol, Clayton, Vic, Australia
基金
英国医学研究理事会;
关键词
diabetic nephropathy; renal fibrosis; TGF-beta; GLYCATION END-PRODUCTS; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; HUMAN MESANGIAL CELLS; ERK MAP KINASE; COLLAGEN EXPRESSION; ANGIOTENSIN-II; POTENTIAL ROLE; HUMAN LUNG; RECEPTOR; HYPERTENSION;
D O I
10.1038/ki.2010.374
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cell division autoantigen 1 (CDA1) modulates cell proliferation and transforming growth factor-beta (TGF-beta) signaling in a number of cellular systems; here we found that its levels were elevated in the kidneys of two animal models of diabetic renal disease. The localization of CDA1 to tubular cells and podocytes in human kidney sections was similar to that seen in the rodent models. CDA1 small interfering RNA knockdown markedly attenuated, whereas its overexpression increased TGF-beta signaling, modulating the expression of TGF-beta, TGF-beta receptors, connective tissue growth factor, collagen types I, Ill, IV, and fibronectin genes in HK-2 cells. CDA1 and TGF-beta together were synergistic in stimulating TGF-beta signaling and target gene expression. CDA1 knockdown effectively blocked TGF-beta-stimulated expression of collagen genes. This was due to its ability to modulate the TGF-beta type I, but not the type II, receptor, leading to increased phosphorylation of Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinase. Furthermore, the Smad3 inhibitor, SIS3, markedly attenuated the activities of CDA1 in stimulating TGF-beta signaling as well as gene expression of collagens I, III, and IV. Thus, our in vitro and in vivo findings show that CDA1 has a critical role in TGF-beta signaling in the kidney. Kidney International (2011) 79, 199-209; doi:10.1038/ki.2010.374; published online 20 October 2010
引用
收藏
页码:199 / 209
页数:11
相关论文
共 50 条
  • [2] Transforming growth factor-β1 and diabetic nephropathy
    Chang, Albert S.
    Hathaway, Catherine K.
    Smithies, Oliver
    Kakoki, Masao
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (08) : F689 - F696
  • [3] Transforming growth factor-β in diabetic nephropathy
    Karima Y. Ahmed
    Walaa F. El-Bazz
    Hend A. Mohamed
    Maha M. Elkeshky
    The Egyptian Journal of Internal Medicine, 2013, 25 (1) : 20 - 26
  • [4] Transforming growth factor-β1 in children with diabetic nephropathy
    Happy Sawires
    Osama Botrous
    Abdelmegeed Aboulmagd
    Nadia Madani
    Osama Abdelhaleem
    Pediatric Nephrology, 2019, 34 : 81 - 85
  • [5] Transforming growth factor-β in human diabetic nephropathy -: Effects of ACE inhibition
    Langham, Robyn G.
    Kelly, Darren J.
    Zhang, Yuan
    Cordonnier, Daniel J.
    Pinel, Nicole
    Zaoui, Phillipe
    Gilbert, Richard E.
    DIABETES CARE, 2006, 29 (12) : 2670 - 2675
  • [6] Hepatocyte growth factor and transforming growth factor-β1 balance in experimental diabetic nephropathy
    Cruzado, JM
    Lloberas, N
    Torras, J
    Riera, M
    Fillat, C
    Herrero, D
    Aran, JM
    Castelao, AM
    Grinyo, JM
    DIABETES, 2002, 51 : A181 - A181
  • [7] Transforming growth factor-β1 in IDDM patients with and without diabetic nephropathy
    Korpinen, E
    Groop, PH
    Fagerudd, J
    Teppo, AM
    Åkerblom, HK
    Vaarala, O
    DIABETOLOGIA, 1998, 41 : A39 - A39
  • [8] Transforming growth factor-β/Smad signalling in diabetic nephropathy
    Lan, Hui Yao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2012, 39 (08): : 731 - 738
  • [9] Involvement of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy
    Ziyadeh F.N.
    Isono M.
    Chen S.
    Clinical and Experimental Nephrology, 2002, 6 (3) : 125 - 129
  • [10] TGF-β (transforming growth factor-β), keystone in diabetic nephropathy
    López-Casillas, F
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2000, 52 (05): : 487 - 490